Faithward Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Faithward Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-86	Closed	-$4K	–	302
2021 Q3	$4K	Hold	86	–	–	﹤0.01%	265
2021 Q2	$4K	Hold	86	–	–	﹤0.01%	253
2021 Q1	$4K	Hold	86	–	–	﹤0.01%	236
2020 Q4	$4K	Hold	86	–	–	﹤0.01%	113
2020 Q3	$4K	Hold	86	–	–	﹤0.01%	203
2020 Q2	$4K	Buy	+86	New	+$3.55K	﹤0.01%	203

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Centaurus Financial Anaheim, California $2.59B AUM 31.63% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Faithward Advisors's XPH Position: Q4 2021 in Review

Faithward Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2021, closing a stake of 86 shares — an estimated $4K sold.

Faithward Advisors first reported a position in XPH in Q2 2020 and held it in 6 quarters. The position peaked at $4K in Q3 2021. 77 funds tracked by Wall St. Rank hold XPH as of Q4 2021.

Faithward Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
Faithward Advisors sold 86 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2021, an estimated $4K.
Faithward Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2020 and held it in 6 quarters.
Faithward Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $4K in Q3 2021.
77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2021.

Based on Faithward Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.